Name recognition and “familiarity” with Novo Nordiisk’s oral Wegovy has contributed to its rapid uptake in its battle with Lilly’s oral GLP-1 Foundayo, according to Spherix analyst Jim Hickey, who conducts monthly surveys with doctors who prescribe the treatments.

Pfizer’s CFO Dave Denton will officially depart in August, leaving SVP of finance Cecile Guegan to take up his post in the interim.

Four years after Spero Therapeutics received a complete response letter from the FDA, rejecting its oral treatment for complicated urinary tract infections, the company and its partner GSK have pushed Utebzi across the finish line.

GSK has launched the first direct-to-consumer TV spot for Exdensur, stepping up promotion of an asthma drug that the company is tipping to generate blockbuster sales.

With good-but-not-great updated data on its approved oncology combo of avutometinib plus defactinib in first-line metastatic pancreatic cancer, Verastem Oncology will now channel its primary R&D efforts toward other pipeline darlings.

Eighteen months after Novo Nordisk purchased a plant in the Czech Republic from Novavax, the Danish drugmaker said it is set to kick off the manufacturing of ingredients for next-generation diabetes and obesity drugs at the facility. The company also announced locally that it will invest $29 million in its […]